,5 SYK also mediates proinflammatory responses induced by IgA1 derived from patients with IgA nephropathy,6 and full results from a Phase II clinical study assessing SYK inhibition with fostamatinib in proliferative IgA nephropathy are awaited (NCT02112838). The gene discussed is SYK; the disease is IgA glomerulonephritis.